Abstract
Low doses of piribedil (0.25–5.0 mg/kg) administered acutely produced reliable decrements in locomotor activity in thirsty and non-thirsty animals, the greatest effect occurring at the highest dose. A sequence of ten daily injections of piribedil produced indications of the development of tolerance, at the two highest doses (2.5 and 5.0 mg/kg) in thirsty animals. The smallest doses used, given either acutely or chronically, produced a weak enhancement of drinking behaviour within the first 15 min of a drinking test, as shown by a reduction in latency to drink and an increase in the amount of water consumption. Tolerance did develop with respect to drinking behaviour; animals treated chronically with piribedil displayed higher levels of drinking at several dose levels when compared with acutely treated subjects. The tolerance displayed at the two highest doses could have a close affinity with that shown with regard to locomotor activity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blundell JE, Latham CJ (1979) Pharmacology of food and water intake. In: Brown K, Cooper SJ (eds) Chemical influences on behaviour. Academic Press, London, p 201
Carlsson A (1975) Receptor-mediated control of dopamine metabolism. In: Usdin E, Bunney WE (eds) Pre- and postsynaptic receptors. Marcel Dekker, New York, p 49
Cools AR, van Rossum JM (1976) Excitation-mediating and inhibition-mediating dopamine-receptors: a new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data. Psychopharmacologia 45:243–254
Cooper SJ, Dourish CT (1979) Sedation, stereotypy and the inhibition of drinking after administration of ET 495 in the rat. Br J Pharmacol 66:481 P
Corrodi H, Farnebo LO, Fuxe K, Hamberger B, Ungerstedt U (1972) ET 495 and brain catecholamine mechanisms: evidence for stimulation of dopamine receptors. Eur J Pharmacol 20:195–204
Corsini GU, Del Zompo M, Manconi S, Cianchetti C, Mangoni A, Gessa GL (1977b) Sedative, hypnotic, and antipsychotic effects of low doses of apomorphine in man. In: Costa E, Gessa GL (eds) Nonstriatal dopaminergic neurons. Advances in biochemical psychopharmacology, vol 16. Raven Press, New York, p 645
Corsini GU, Del Zompo M, Manconi S, Piccardi MP, Onali PL, Mangoni A (1977a) Evidence for dopamine receptors in the human brain mediating sedation and sleep. Life Sci 20:1613–1618
Costentin J, Marcais H, Portais P, Schwartz JC (1977) Tolerance to hypokinesia elicited by dopamine agonists in mice: hyposensitization of autoreceptors? Life Sci 20:883–886
Costall B, Naylor RJ (1974) Stereotyped and circulating behaviour induced by dopaminergic agonists after lesions of the mid-brain raphe nuclei. Eur J Pharmacol 29:206–222
Creese I (1974) Behavioural evidence of dopamine receptor stimulation by piribedil (ET 495) and its metabolite S 584. Eur J Pharmacol 28:55–58
Di Chiara G, Gessa GL (1978) Pharmacology and neurochemistry of apomorphine. Adv Pharmacol Chemother 15:87–160
Fisher AE (1973) Relationships between cholinergic and other diposogens in the central mediation of thirst. In: Epstein AN, Kissileff HR, Stellar E (eds) The neuropsychology of thirst. Winston, Washington DC, p 243
Fitzsimons JT, Setler PE (1975) The relative importance of central nervous catecholaminergic and cholinergic mechanisms in drinking in response to angiotensin and other thirst stimuli. J Physiol 250:613–631
Iversen LL, Quik M, Emson PC, Dowling JE, Watling KK (1980) Further evidence for the existence of multiple receptors for dopamine in the central nervous system. In: Pepeu G, Kuhar MJ, Enna SJ (eds) Receptors for neurotransmitters and peptide hormones. Raven Press, New York, p 193
Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93–96
Maj J, Przewlocka B, Kukulka L (1977) Sedative action of low doses of dopaminergic agents. Pol J Pharmacol Pharm 29:11–21
Poat JA, Summers G, Woodruff GN (1980) The effects of centrally administered dopamine and 2-amino-6, 7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) on water and food intake in the rat. Br J Pharmacol 70:151–152
Setler PE (1975) Noradrenergic and dopaminergic influences on thirst. In: Peters G, Fitzsimons JT, Peters-Haefli L (eds) Control mechanisms of drinking. Springer, Berlin Heidelberg New York, p 62
Spano PF, Memo M, Stefanini E, Fresia P, Trabucchi M (1980) Detection of multiple receptors for dopamine. In: Pepeu G, Kuhar MJ, Enna SJ (eds) Receptors for neurotransmitters and peptide hormones. Raven Press, New York, p 243
Strömberg U (1970) DOPA effects on motility in mice; potentiation by MK 485 and dexchlorpheniramine. Psychopharmacologia 18:58–67
Strömbom U (1975) On the functional role of pre- and postsynaptic catecholamine receptors in brain. Acta physiol Scand Suppl 431
Strömbom U (1976) Catecholamine receptor agonists. Effects on motor activity and rate of tyrosine hydroxylation in mouse brain. Naunyn-Schmiedeberg's Arch Pharmacol 292:167–176
Thornburg JE, Moore KE (1974) A comparison of effects of apomorphine and ET 495 on locomotor activity and circling behaviour in mice. Neuropharmacology 13:189–197
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dourish, C.T., Cooper, S.J. Effects of acute or chronic administration of low doses of a dopamine agonist on drinking and locomotor activity in the rat. Psychopharmacology 72, 197–202 (1981). https://doi.org/10.1007/BF00431656
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00431656